Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleLeukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
- Where
- Beijing
- Életkor
- 6 év to 60 év
- People
- 210
- Run by
- Peking University People's Hospital
See details and how to joinNCT07537738 - No phaseCsak meghívásosOrganoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors
- Where
- Shanghai
- Életkor
- 1 év to 18 év
- People
- 30
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07528079 - 1. fázisNot yet taking people in KínaA Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies
- Where
- Shanghai, Wuhan
- Életkor
- 2 év to 70 év
- People
- 55
- Run by
- Kousai Bio Co., Ltd.
See details and how to joinNCT07532746 - No phaseNot yet taking people in KínaClinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery
- Where
- Hangzhou, Wenzhou, Wuhan
- Életkor
- 0 év to 17 év
- People
- 64
- Run by
- Hangzhou Kangji Weijing Medical Robotics Co., Ltd.
See details and how to joinNCT07530133 - No phaseTaking peopleSingle-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
- Where
- Guangzhou
- People
- 240
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07265544 - No phaseTaking peopleDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
- Where
- Fuzhou, Guangzhou, Nanjing, Qingdao, Shanghai, Shenzhen, Tianjing
- People
- 200 worldwide
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07528066 - No phaseTaking peopleClinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors
- Where
- Beijing
- Életkor
- 15 év to 70 év
- People
- 20
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07529002 - 1. fázisTaking peopleStudy to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
- Where
- Beijing, Hangzhou, Jinan, Suzhou, Tianjin
- Életkor
- Up to 18 év
- People
- 15
- Run by
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07529782 - No phaseNot yet taking people in KínaKSD-101 in Patients With EBV-associated Hematological Malignancies
- Where
- Qionghai
- Életkor
- 12 év and over
- People
- 80
- Run by
- Ruijin Hospital
See details and how to joinNCT07525024 - 1. fázisTaking peopleA Study of HQP1351 in Patients With GIST or Other Solid Tumors
- Where
- Beijing, Guangzhou, Shanghai, Wuhan, Zhengzhou
- Életkor
- 12 év and over
- People
- 100
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT03594422 - No phaseTaking peopleSerial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
- Where
- Guangzhou
- People
- 200
- Run by
- Sun Yat-sen University
See details and how to joinNCT07516678 - No phaseCsak meghívásosThe Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
- Where
- Guangzhou
- Életkor
- 5 év to 18 év
- People
- 138
- Run by
- Sun Yat-sen University
See details and how to joinNCT07515430 - No phaseCsak meghívásosLongitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
- Where
- Beijing
- People
- 138
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06509022 - 2. fázisTaking peopleVenetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia
- Where
- Beijing
- Életkor
- 14 év to 60 év
- People
- 204
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07512700 - 2. fázisTaking peopleClinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Beijing
- Életkor
- 14 év to 75 év
- People
- 200
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT06084819 - 1/2. fázisTaking peopleNanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 50
- Run by
- Peking University People's Hospital
See details and how to joinNCT06880913 - No phaseTaking peopleDigital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
- Where
- Beijing
- People
- 100
- Run by
- Peking University People's Hospital
See details and how to joinNCT07500441 - No phaseTaking peopleA Retrospective Real-World Study Based on RATIONALE-307
- Where
- Beijing
- People
- 109
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07478809 - No phaseTaking peopleMagnetoencephalography in Children
- Where
- Shanghai
- Életkor
- 1 hónap to 18 év
- People
- 1500
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT06668519 - 2. fázisTaking peopleFull-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
- Where
- Suzhou
- Életkor
- 15 év and over
- People
- 26
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06985485 - 2. fázisTaking peopleStudy of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
- Where
- Beijing
- Életkor
- 14 év and over
- People
- 25
- Run by
- Daihong Liu
See details and how to joinNCT07489534 - 1. fázisTaking peopleTrilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors
- Where
- Shijiazhuang
- People
- 100
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07490236 - 1. fázisNot yet taking people in KínaClinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia
- Where
- Fuzhou
- Életkor
- 14 év and over
- People
- 6
- Run by
- Fujian Medical University
See details and how to joinNCT07491263 - 4. fázisTaking peopleRuxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial
- Where
- Beijing
- Életkor
- 14 év to 75 év
- People
- 200
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07101588 - 3. fázisTaking peopleMRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
- Where
- Shanghai, Suzhou
- Életkor
- 14 év to 70 év
- People
- 594
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07463651